Acute coronary syndrome and recurrent colitis as immune-related adverse events in a lung cancer patient

被引：8

作者：

Cancela-Diez, Barbara ^{[1
]}

Gomez-De Rueda, Felix ^{[2
]}

Antolinos Perez, Maria J. ^{[3
]}

Jimenez-Morales, Alberto ^{[1
]}

Lopez-Hidalgo, Javier L. ^{[4
]}

机构：

[1] Univ Hosp Virgen Nieves, Pharm Unit, Granada, Spain

[2] Univ Hosp Jaen, Pharm Unit, Jaen, Spain

[3] Univ Hosp Virgen Nieves, Cardiol Unit, Granada, Spain

[4] Univ Hosp Virgen Nieves, Pathol Unit, Granada, Spain

来源：

JOURNAL OF ONCOLOGY PHARMACY PRACTICE | 2020年 / 26卷 / 01期

关键词：

Nivolumab; acute coronary syndrome; immune-relate adverse events; lung cancer; recurrent colitis;

D O I：

10.1177/1078155219865596

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Immune checkpoint inhibitors have become a target for pharmacological research in lung cancer. Immune-related adverse events (irAEs) such as pneumonitis, colitis, hepatitis and endocrinopathies have been well characterized in immune checkpoint inhibitors, but coronary toxicities, like acute coronary syndrome, are poorly described. Herein, we report a possible acute coronary syndrome as immune-related adverse event in a lung cancer patient.

引用

页码：252 / 255

页数：4

共 9 条

[1] Histopathologic Features of Colitis Due to Immunotherapy With Anti-PD-1 Antibodies [J].

Chen, Jonathan H. ;

Pezhouh, Maryam K. ;

Lauwers, Gregory Y. ;

Masia, Ricard .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (05) :643-654

[2] Coronary Toxicities of Anti-PD-1 and Anti-PD-L1 Immunotherapies: a Case Report and Review of the Literature and International Registries [J].

Ferreira, Marion ;

Pichon, Eric ;

Carmier, Delphine ;

Bouquet, Emilie ;

Pageot, Cecile ;

Bejan-Angoulvant, Theodora ;

Campana, Marion ;

Vermes, Emmanuelle ;

Marchand-Adam, Sylvain .

TARGETED ONCOLOGY, 2018, 13 (04) :509-515

[3] Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis [J].

Foks, A. C. ;

Kuiper, J. .

BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 (22) :3940-3955

[4] Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes [J].

Freeman-Keller, Morganna ;

Kim, Youngchul ;

Cronin, Heather ;

Richards, Allison ;

Gibney, Geoffrey ;

Weber, Jeffrey S. .

CLINICAL CANCER RESEARCH, 2016, 22 (04) :886-894

[5] Fulminant Myocarditis with Combination Immune Checkpoint Blockade [J].

Johnson, Douglas B. dbj ;

Balko, Justin M. jmb ;

Compton, Margaret L. mlc ;

Chalkias, Spyridon sc ;

Gorham, Joshua jc ;

Xu, Yaomin yx ;

Hicks, Mellissa mh ;

Puzanov, Igor ip ;

Alexander, Matthew R. mra ;

Bloomer, Tyler L. tlb ;

Becker, Jason R. jrb ;

Slosky, David A. das ;

Phillips, Elizabeth J. ejp ;

Pilkinton, Mark A. map ;

Craig-Owens, Laura lco ;

Kola, Nina nk ;

Plautz, Gregory gp ;

Reshef, Daniel S. dsr ;

Deutsch, Jonathan S. jsd ;

Deering, Raquel P. rpd ;

Olenchock, Benjamin A. bao ;

Lichtman, Andrew H. ahl ;

Roden, Dan M. dmr ;

Seidman, Christine E. ces ;

Koralnik, Igor J. ijk ;

Seidman, Jonathan G. jgs ;

Hoffman, Robert D. rdh ;

Taube, Janis M. jmt ;

Diaz, Luis A. Jr lad ;

Anders, Robert A. raa ;

Sosman, Jeffrey A. jas ;

Moslehi, Javid J. jjm .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (18) :1749-1755

[6] A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].

NARANJO, CA ;

BUSTO, U ;

SELLERS, EM ;

SANDOR, P ;

RUIZ, I ;

ROBERTS, EA ;

JANECEK, E ;

DOMECQ, C ;

GREENBLATT, DJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :239-245

[7] Anti-PD-1-Related Pneumonitis during Cancer Immunotherapy [J].

Nishino, Mizuki ;

Sholl, Lynette M. ;

Hodi, F. Stephen .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (03) :288-290

[8] Acute coronary syndrome as a possible immune-related adverse event in a lung cancer patient achieving a complete response to anti-PD-1 immune checkpoint antibody [J].

Tomita, Y. ;

Sueta, D. ;

Kakiuchi, Y. ;

Saeki, S. ;

Saruwatari, K. ;

Sakata, S. ;

Jodai, T. ;

Migiyama, Y. ;

Akaike, K. ;

Hirosako, S. ;

Fujisue, K. ;

Yamamura, S. ;

Miyazaki, S. ;

Takashio, S. ;

Izumiya, Y. ;

Nakamura, K. ;

Tsujita, K. ;

Ichiyasu, H. ;

Fujii, K. .

ANNALS OF ONCOLOGY, 2017, 28 (11) :2893-2895

[9] Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer [J].

Topalian, Suzanne L. ;

Hodi, F. Stephen ;

Brahmer, Julie R. ;

Gettinger, Scott N. ;

Smith, David C. ;

McDermott, David F. ;

Powderly, John D. ;

Carvajal, Richard D. ;

Sosman, Jeffrey A. ;

Atkins, Michael B. ;

Leming, Philip D. ;

Spigel, David R. ;

Antonia, Scott J. ;

Horn, Leora ;

Drake, Charles G. ;

Pardoll, Drew M. ;

Chen, Lieping ;

Sharfman, William H. ;

Anders, Robert A. ;

Taube, Janis M. ;

McMiller, Tracee L. ;

Xu, Haiying ;

Korman, Alan J. ;

Jure-Kunkel, Maria ;

Agrawal, Shruti ;

McDonald, Daniel ;

Kollia, Georgia D. ;

Gupta, Ashok ;

Wigginton, Jon M. ;

Sznol, Mario .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2443-2454

← 1 →